APA (7th ed.) Citation

L, Z., AJ, T., KR, C., ML, G., P, M., JF, F., . . . JR, B. (2026). Who receives psychiatry-focused pharmacogenomic testing, and is it associated with prescribing patterns and acute care utilisation in depression? Real-world evidence from a large health system. EBioMedicine, 128, 106275. https://doi.org/10.1016/j.ebiom.2026.106275

Chicago Style (17th ed.) Citation

L, Zhang, Tholkes AJ, Cullen KR, Gunlicks-Stoessel ML, Mroz P, Farley JF, Johnson SG, and Bishop JR. "Who Receives Psychiatry-focused Pharmacogenomic Testing, and Is It Associated with Prescribing Patterns and Acute Care Utilisation in Depression? Real-world Evidence from a Large Health System." EBioMedicine 128 (2026): 106275. https://doi.org/10.1016/j.ebiom.2026.106275.

MLA (9th ed.) Citation

L, Zhang, et al. "Who Receives Psychiatry-focused Pharmacogenomic Testing, and Is It Associated with Prescribing Patterns and Acute Care Utilisation in Depression? Real-world Evidence from a Large Health System." EBioMedicine, vol. 128, 2026, p. 106275, https://doi.org/10.1016/j.ebiom.2026.106275.